Cholesterol-lowering drugs linked to kidney damage
Newsmakers > Disability rights film festival at McGill
Big Bang's baby pics to be 'beautiful,' but 'blurry'
Scientist at Work Blog: A Tale of Two Frozen Lakes
Family meals have calming effect on troubled teenagers
Clinical Pharmacology and Toxicology Program Receives Full Accrediation
Dear Clinical Pharmacology and Toxicology Program Committee Members and Faculty and Faculty Members of the Department of Psychiatry;
Department of Psychiatry's Residency Program Receives Full Accreditation Status
Dear all,
It is my great pleasure to announce to you that our program has received full accreditation status from the Royal College of Physicians and Surgeons of Canada. The surveyors were impressed with the overall quality of the program, the dedicated faculty members, the high caliber of residents, and the positive atmosphere of collaboration and commitment to educational excellence. I would like to thank all of you for your help with the accreditation and your constant support and participation in the residency program.
Sincerely,
Researchers identify a promising target for Multiple Sclerosis treatments
A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre’s (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS).
Nine McGill researchers among recent CRCs announced
Nine McGill researchers are among the recipients of the newly awarded and renewed Canada Research Chairs announced today by the Honourable Gary Goodyear, Minister of State (Science and Technology) at Western University in London, Ontario.